Berry Consultants announced today that it has reached an agreement with Tessella to acquire 100% ownership of FACTS. Previously, FACTS was jointly developed and owned by Berry Consultants and Tessella, but this agreement gives Berry Consultants full ownership of the software. FACTS (Fixed and Adaptive Clinical Trial Simulator) is the most powerful, versatile, and fastest clinical trial simulation tool on the market today. FACTS allows biostatisticians and clinical teams to rapidly design and compare innovative, advanced, clinical trial designs. As part of the agreement, Tessella will remain as an IT service contractor of Berry Consultants providing support and transitional assistance as needed.
“FACTS is a powerful tool for the clinical trial industry today, but even more looking forward,” said Dr. Scott Berry, President of Berry Consultants. “We believe in the future all clinical trials will require the type of detailed, complex, simulations that FACTS provides — it is the flight simulator of a clinical trial. It allows trials to be run millions of times before the actual trial—to think through all the possibilities and outcomes before they occur. We appreciate Tessella’s partnership, support, and expertise in developing FACTS. It is the natural progression and growth of Berry Consultants to expand and develop FACTS going forward.”